Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants

Author:

Dash Pinki1ORCID,Hakim Al12,Akter Aklima1,Banna Hasan Al1ORCID,Kaisar M. Hasanul1ORCID,Aktar Amena1,Jahan Sultana Rownok1,Ferdous Jannatul1,Basher Salima Raiyan1,Kamruzzaman Mohammad13,Chowdhury Fahima1ORCID,Akter Afroza1,Tauheed Imam1,Weil Ana A.4,Charles Richelle C.56ORCID,Calderwood Stephen B.567,Ryan Edward T.568ORCID,LaRocque Regina C.567,Harris Jason B.7910,Bhuiyan Taufiqur Rahman1ORCID,Qadri Firdausi1ORCID

Affiliation:

1. Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh

2. Department of Genetic Engineering and Biotechnology, Jagannath University, Dhaka, Bangladesh

3. Department of Biochemistry and Molecular Biology, Mawlana Bhashani Science and Technology University, Santosh, Tangail, Bangladesh

4. Department of Medicine, University of Washington, Seattle, Washington, USA

5. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA

6. Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

7. Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA

8. Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA

9. Division of Global Health, Massachusetts General Hospital for Children, Boston, Massachusetts, USA

10. Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA

Abstract

ABSTRACT Vaccination is important to prevent cholera. There are limited data comparing anti-O-specific polysaccharide (OSP) and anti-cholera toxin-specific immune responses following oral whole-cell with cholera toxin B-subunit (WC-rBS) vaccine (Dukoral, Valneva) administration in different age groups. An understanding of the differences is relevant because young children are less well protected by oral cholera vaccines than older children and adults. We compared responses in 50 adults and 49 children (ages 2 to <18) who were administered two doses of WC-rBS at a standard 14-day interval. All age groups had significant IgA and IgG plasma-blast responses to the OSP and cholera toxin B-subunit (CtxB) antigens that peaked 7 days after vaccination. However, in adults and older children (ages 5 to <18), antibody responses directed at the OSP antigen were largely IgA and IgG, with a minimal IgM response, while younger children (ages 2 to <5) mounted significant increases in IgM with minimal increases in IgA and IgG antibody responses 30 days after vaccination. In adults, anti-OSP and CtxB memory B-cell responses were detected after completion of the vaccination series, while children only mounted CtxB-specific IgG memory B-cell responses and no OSP-memory B-cell responses. In summary, children and adults living in a cholera endemic area mounted different responses to the WC-rBS vaccine, which may be a result of more prior exposure to Vibrio cholerae in older participants. The absence of class-switched antibody responses and memory B-cell responses to OSP may explain why protection wanes more rapidly after vaccination in young children compared to older vaccinees. IMPORTANCE Vaccination is an important strategy to prevent cholera. Though immune responses targeting the OSP of V. cholerae are believed to mediate protection against cholera, there are limited data on anti-OSP responses after vaccination in different age groups, which is important as young children are not well protected by current oral cholera vaccines. In this study, we found that adults mounted memory B-cell responses to OSP, which were not seen in children. Adults and older children mounted class-switched (IgG and IgA) serum antibody responses to OSP, which were not seen in young children who had only IgM responses to OSP. The lack of class-switched antibody responses and memory B-cell responses to OSP in younger participants may be due to lack of prior exposure to V. cholerae and could explain why protection wanes more rapidly after vaccination in young children.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

HHS | NIH | Fogarty International Center

Publisher

American Society for Microbiology

Reference37 articles.

1. Cholera

2. Tracking progress towards global drinking water and sanitation targets: A within and among country analysis

3. Cholera vaccines: WHO position paper;World Health Organization;Wkly Epidemiol Rec,2010

4. Cholera vaccines: WHO position paper – August 2017;World Health Organization;Wkly Epidemiol Rec,2017

5. Ending cholera a global roadmap to 2030;World Health Organization;GTFCC,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3